1. Home
  2. Labeler Index
  3. Aurobindo Pharma Limited
  4. 65862-249
  5. Product Images: Alfuzosin Hydrochloride

Product Images Alfuzosin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Alfuzosin Hydrochloride NDC 65862-249 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure-1 - alfuzosin fig1

Figure-1 - alfuzosin fig1

This appears to be a graph displaying the plasma concentration of Alfuzosin over time (in hours). Without additional context or further information, it is difficult to provide a more detailed description or analysis.*

Figure 2 — Mean Change from Baseline in IPSS Total Symptom Score: Trial 1 - alfuzosin fig2

Figure 2 — Mean Change from Baseline in IPSS Total Symptom Score: Trial 1 - alfuzosin fig2

The text appears to be a partial excerpt from a medical research article or report. It includes a comparison of the effectiveness of a placebo treatment versus a drug called Alfuzosin hydrochloride in reducing symptoms measured by IPSS Total Symptom Score. The mean change in symptoms over time is represented graphically in Figure 2 and the statistical significance of the results is indicated by p<0.001.*

Figure 3 — Mean Change from Baseline in IPSS Total Symptom Score: Trial 2 - alfuzosin fig3

Figure 3 — Mean Change from Baseline in IPSS Total Symptom Score: Trial 2 - alfuzosin fig3

This is a graph showing the mean change from baseline in IPSS Total Symptom Score for Trial 2, with days of treatment on the X-axis and Hycom on the Y-axis. The text at the beginning appears to be random characters and is not readable.*

Figure 4 — Mean Change from Baseline in IPSS Total Symptom Score: Trial 3 - alfuzosin fig4

Figure 4 — Mean Change from Baseline in IPSS Total Symptom Score: Trial 3 - alfuzosin fig4

Figure 5 — Mean Change from Baseline in Peak Urine Flow Rate (mL/s): Trial 1 - alfuzosin fig5

Figure 5 — Mean Change from Baseline in Peak Urine Flow Rate (mL/s): Trial 1 - alfuzosin fig5

Figure 6 — Mean Change from Baseline in Peak Urine Flow Rate (mL/s): Trial 2 - alfuzosin fig6

Figure 6 — Mean Change from Baseline in Peak Urine Flow Rate (mL/s): Trial 2 - alfuzosin fig6

The text is a partial description of a figure showing the mean change from baseline in peak urine flow rate in days of treatment of a certain trial.*

Figure 7 — Mean Change from Baseline in Peak Urine Flow Rate (mL/s): Trial 3 - alfuzosin fig7

Figure 7 — Mean Change from Baseline in Peak Urine Flow Rate (mL/s): Trial 3 - alfuzosin fig7

The text appears to be a graph that shows the Mean Change from Baseline in Peak Urine Flow Rate (uL/s) for Trial 3 after a treatment period of 20 days. The values on the x-axis were not included in the text. Therefore, a proper description cannot be provided.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (30 Tablet Bottle) - alfuzosin fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (30 Tablet Bottle) - alfuzosin fig8

This is a description of a medication named Alfuzosin Hydrochloride Extended-Release Tablets USP, which contains 10mg Alfuzosin Hydrochloride USP. The medication is distributed by Aurobindo Pharma USA, Inc. and comes in a package of 30 tablets. The usual dosage is mentioned in the package insert. The medication should be stored in a tight and light-resistant container between 20° to 25°C (68° to 77°F); with excursions permitted to 15° to 30°C (59° to 86°F). It should be kept out of reach of children and protected from light and moisture. The code TS/DRUGS/19/1993 is also mentioned. Made in India.*

Structure - alfuzosin str

Structure - alfuzosin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.